YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
HKEX:1558.HK
8.19 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 1,674.413 | 923.543 | 1,131.121 | 2,044.967 | 2,779.138 | 593.746 | 887.183 | 1,212.072 | 1,353.651 | 86.554 | 32.367 |
| Short Term Investments
| 18.686 | 290 | 0 | 0 | 0 | 0 | 346.519 | 238.988 | 33 | 0 | 0 |
| Cash and Short Term Investments
| 1,674.413 | 1,213.543 | 1,131.121 | 2,044.967 | 2,779.138 | 593.746 | 1,233.702 | 1,451.06 | 1,386.651 | 86.554 | 32.367 |
| Net Receivables
| 2,072.611 | 1,005.817 | 479.041 | 460.509 | 2,196.381 | 969.763 | 721.91 | 328.738 | 250.094 | 133.128 | 139.269 |
| Inventory
| 409.05 | 315.027 | 279.696 | 378.268 | 206.62 | 195.999 | 99.671 | 116.162 | 162.021 | 203.834 | 225.322 |
| Other Current Assets
| 1,896.982 | 2,769.633 | 167.518 | 380.366 | 148.57 | 25.856 | 13.347 | 5.508 | 11.158 | 54.729 | 462.605 |
| Total Current Assets
| 6,053.056 | 5,014.02 | 2,057.376 | 3,264.11 | 5,330.709 | 1,785.364 | 2,068.63 | 1,901.468 | 1,809.924 | 478.245 | 859.563 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 3,849.668 | 3,518.765 | 3,216.555 | 2,835.706 | 2,025.507 | 1,351.479 | 670.225 | 495.682 | 462.5 | 463.635 | 770.987 |
| Goodwill
| 0 | 0 | 75.896 | 75.896 | 75.896 | 75.896 | 75.896 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 2,571.761 | 1,782.383 | 2,070.644 | 1,536.43 | 534.047 | 369.133 | 317.013 | 81.767 | 83.699 | 85.631 | 0 |
| Goodwill and Intangible Assets
| 2,571.761 | 1,782.383 | 2,146.54 | 1,612.326 | 609.943 | 445.029 | 392.909 | 81.767 | 83.699 | 85.631 | 0 |
| Long Term Investments
| 32.158 | 5,160.539 | 1,789.621 | 4,407.387 | 2,539.689 | 1,764.42 | 1,034.891 | 402.5 | 368.409 | 372.157 | 0 |
| Tax Assets
| 237.686 | 140.609 | 65.318 | 40.645 | 95.761 | 32.088 | 28.243 | 11.415 | 10.392 | 5.847 | 0 |
| Other Non-Current Assets
| 0 | -5,301.148 | -65.318 | -4,448.032 | -2,635.45 | -1,796.508 | -1,063.134 | -495.682 | -462.5 | -463.635 | 27.566 |
| Total Non-Current Assets
| 6,691.273 | 5,301.148 | 7,152.716 | 4,448.032 | 2,635.45 | 1,796.508 | 1,063.134 | 495.682 | 462.5 | 463.635 | 798.553 |
| Total Assets
| 12,744.329 | 11,889.8 | 10,541.581 | 9,561.267 | 9,912.339 | 4,560.94 | 3,775.975 | 2,831.109 | 2,577.415 | 949.531 | 1,658.116 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 200.088 | 178.614 | 193.473 | 244.942 | 184.697 | 80.554 | 59.867 | 24.306 | 33.411 | 53.744 | 37.672 |
| Short Term Debt
| 2,319.877 | 3,130.306 | 48.477 | 2,820.804 | 132.66 | 53.399 | 10 | 70 | 105 | 270 | 669.774 |
| Tax Payables
| 297.343 | 160.598 | 250.755 | 27.564 | 272.214 | 97.677 | 146.719 | 45.13 | 22.183 | 16.006 | 0 |
| Deferred Revenue
| -0.359 | -3,130.306 | -48.477 | -2,820.804 | -132.66 | -53.399 | -10 | -70 | -105 | -270 | 0 |
| Other Current Liabilities
| 1,812.614 | 4,762.167 | 1,044.591 | 3,916.271 | 2,126.952 | 732.244 | 580.88 | 259.975 | 237.755 | 392.246 | 47.814 |
| Total Current Liabilities
| 4,332.22 | 4,940.781 | 1,238.064 | 4,161.213 | 2,311.649 | 812.798 | 640.747 | 284.281 | 271.166 | 445.99 | 755.26 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 289.451 | 691.529 | 3,145.025 | 189.853 | 2,902.6 | 0 | 10 | 20 | 90 | 145 | 338.27 |
| Deferred Revenue Non-Current
| 187.145 | 187.489 | 137.73 | 106.542 | 74.935 | 69.214 | 64.642 | 69.021 | 73.4 | 81.286 | 0 |
| Deferred Tax Liabilities Non-Current
| -187.145 | 504.04 | 3,007.295 | 83.311 | 2,827.665 | 0 | -54.642 | -49.021 | 16.6 | 63.714 | 0 |
| Other Non-Current Liabilities
| 187.145 | -691.529 | -3,145.025 | -189.853 | -2,902.6 | 0 | -10 | -20 | -90 | -145 | 85.665 |
| Total Non-Current Liabilities
| 476.596 | 691.529 | 3,145.025 | 189.853 | 2,902.6 | 69.214 | 10 | 20 | 90 | 145 | 423.935 |
| Total Liabilities
| 4,808.816 | 5,819.799 | 4,520.819 | 4,457.608 | 5,289.184 | 882.012 | 715.389 | 373.302 | 434.566 | 672.276 | 1,179.195 |
| Equity: | |||||||||||
| Preferred Stock
| 439.987 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 879.968 | 879.968 | 879.968 | 879.968 | 448.82 | 452.023 | 452.023 | 450.823 | 450.659 | 170.8 | 170.8 |
| Retained Earnings
| 3,947.144 | 2,394.507 | 2,317.904 | 2,905.553 | 2,726.072 | 1,505.355 | 879.235 | 548.55 | 235.576 | 98.391 | 300.057 |
| Accumulated Other Comprehensive Income/Loss
| 2,668.414 | 2,610.409 | 2,610.409 | 1,105.582 | 1,375.872 | 1,476.578 | 1,476.578 | 1,458.434 | 1,456.614 | 8.064 | 8.064 |
| Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | -142.209 | -0 | 0 | 0 | 0 | 0 | 0 |
| Total Shareholders Equity
| 7,935.513 | 5,884.884 | 5,808.281 | 4,891.103 | 4,408.555 | 3,433.956 | 2,807.836 | 2,457.807 | 2,142.849 | 277.255 | 478.921 |
| Total Equity
| 7,935.513 | 6,070.001 | 6,020.762 | 5,103.659 | 4,623.155 | 3,678.928 | 3,060.586 | 2,457.807 | 2,142.849 | 277.255 | 478.921 |
| Total Liabilities & Shareholders Equity
| 12,744.329 | 11,889.8 | 10,541.581 | 9,561.267 | 9,912.339 | 4,560.94 | 3,775.975 | 2,831.109 | 2,577.415 | 949.531 | 1,658.116 |